Page 34 - JSOM Spring 2026

TABLE S2 STROBE Criteria of the Included Studies
Bondarenko Guryev Lurin Netliukh Prangenberg Shevchuk Trutyak Yarmoliuk Ye Yuste Burianov Formanchuk Khomenko Kuchyn Klapchuk Guriev Khomenko Khomenko Sliesarenko
STROBE Criteria 2024 2024 2024 2024 2024 2024 (b) 2024 2024 2024 2024 2023 2023 2023 (b) 2023 2021 2020 2020 2019 2016
1. Title and abstract clearly describe the Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
study?
2. Rationale and background for the study Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
are provided?
3. Study objectives and hypothesis clearly Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
stated?
4. Study design clearly described? Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
5. Describe the setting, locations, and
relevant dates, including periods of No Yes No Yes Yes No Yes Yes Yes Yes Yes No Yes Yes Yes Yes Yes No Yes
recruitment ?
6. Participant eligibility criteria clearly Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
defined?
7. Clearly define all outcomes, exposures,
predictors, potential confounders, and Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
effect modifiers?
8. Data sources and measurement methods Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
clearly described?
9. Potential biases discussed? No No No No No No No No No No No No No No No No No No No
10. Sample size justification provided? No No No No No No No No No No No No No No No No No No No
11. Explain how quantitative variables were NE NE NE No NE NE NE NE NE No NE NE NE NE NE NE NE NE No
handled in the analyses?

12. Statistical methods described and Yes Yes Yes No Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
appropriate?
13. Report numbers of individuals at each Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
stage of study?
14. Give characteristics of study participants
(e.g. demographic, clinical, social) and Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
information on exposures and potential
confounders?
15. Given Outcome data? Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
16. Main Results presented in detail with Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
appropriate tables/figures?
17. Other analyses? NE NE NE NE NE NE NE NE NE NE NE NE NE NE NE NE NE NE NE
18. Summarize key results? Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
19. Study limitations acknowledged? No No Yes No No Yes No No Yes No No No No No No No No No No
20. Discussion interprets findings in the Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
context of existing literature?
21. Generalizability? NE NE NE NE NE NE NE NE NE NE NE NE NE NE NE NE NE NE NE
22. Ethical considerations and approval Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes Yes
reported?
NE = not evaluated.

32 | JSOM Volume 26, Edition 1 / Spring 2026